| UBS (LUX) EQUITY SICAV - GLOBAL HIGH DIVIDEND (USD) QL-ACC | RVI GLOBAL VALOR | 161,076280 | 30/03/2026 | 5,73% | 42,45% | **** |
| BLACKROCK SYSTEMATIC US EQUITY ABSOLUTE RETURN I2 USD | RETORNO ABSOLUTO | 135,701861 | 31/03/2026 | 5,72% | 18,67% | **** |
| DWS INVEST GOLD AND PRECIOUS METALS EQUITIES LD | MATERIAS PRIMAS | 262,750000 | 31/03/2026 | 5,72% | 176,87% | **** |
| MAN SYSTEMATIC EMERGING MARKETS EQUITY D USD | RVI EMERGENTES | 198,728666 | 30/03/2026 | 5,72% | 57,62% | ***** |
| SCHRODER ISF JAPANESE OPPORTUNITIES A ACC SEK | RVI JAPÓN VALOR | 21,427342 | 31/03/2026 | 5,72% | 47,98% | ** |
| AB SICAV I-US SMALL AND MID-CAP PORTFOLIO S USD | RVI USA SMALL/MID CAP | 100,156549 | 31/03/2026 | 5,71% | · | ND |
| AMUNDI FUNDS EQUITY JAPAN TARGET F2 EUR HGD (C) | RVI JAPÓN | 422,280000 | 31/03/2026 | 5,71% | 105,61% | ***** |
| GOLDMAN SACHS EUROPE CORE EQUITY PORTFOLIO I H USD CAP | RVI EUROPA | 21,168899 | 31/03/2026 | 5,71% | 57,36% | ***** |
| MAN TARGETRISK I USD | MIXTO FLEXIBLE | 202,751654 | 30/03/2026 | 5,71% | 23,53% | *** |
| POLAR CAPITAL BIOTECHNOLOGY I USD DIS | BIOTECNOLOGÍA | 60,680118 | 31/03/2026 | 5,71% | 72,21% | **** |
